Журнал кардиореспираторных исследований 2025. №4

Тема статьи

TROMBOTSITOPENIYA BILAN BEMORLARDA MIOKARD INFARKTI VA INSULTDAN KEYINGI UYQU BUZILISH HOLATLARI (62-65)

Авторы

Mamatkulova Feruza Xaydarovna

Учреждение

Samarqand Davlat Tibbiyot universiteti

Аннотация

Miokard infarkti va insultdan keyingi holat butun dunyo bo‘ylab o‘lim va doimiy nogironlikning asosiy sabablaridan biri bo‘lib qolmoqda [1]. So‘nggi o‘n yil ichida tadqiqotchilar va klinitsistlar uyqu buzilishiga tobora ko‘proq e’tibor qaratmoqdalar, bu nafaqat infarkt yoki insultning umumiy oqibati, balki uning rivojlanishi uchun mustaqil xavf omili bo‘lib xizmat qiladi[2] va reabilitatsion jarayonlarni va bemorlarning hayot sifatiga ta’sir qiladi. O‘tkir serebrovaskulyar buzilish sifatida insult ko‘pincha uyqu buzilishiga olib keladi, shu jumladan uyqusizlik, gipersomniya, obstruktiv uyqu apnoesi (OUA) va uyqu-uyg‘onish siklini tartibga soluvchi miya tuzilmalarining shikastlanishi natijasida yuzaga kelgan haddantashqari uyquchanlik bo‘lgan bemorlarda uyqusizlik, nafas olishning buzilishi va harakatlarning buzilishining turli shakllarining tarqalishi 45– 78%ga yetadi [3, 4].

Ключевые слова

Trombotsitopenik purpura, yurak infarkti, gemorragik insult, insultdan keyingi uyqu buzilishi, obstruktiv uyqu apnoesi, yurak ritmi buzilishi, neyroreabilitatsiya

Литературы

1. Melikyan A. L., Pustovaya YE. I., Svetayeva N. V., Abdul-kadirov K. M., Lisukov I. A. [i dr.]. Natsionalniye 11. klinicheskiye rekomendatsii po diagnostike i lecheniyu pervichnoy immunnoy trombotsitopenii (idiopati-cheskoy trombotsitopenicheskoy purpuri) u vzroslix. Gematologiya i transfuziologiya. 2015;60(1):44-56. [Melikyan A. L., Pustovaya Ye. I., Tsvetayeva N. V., Ab-dulkadyrov K. M., Lisukov I. A. [et al.]. Natsional'nyye klinicheskiye rekomendatsii po diagnostike i lecheniyu pervichnoy immunnoy trombotsitopenii (idiopaticheskoy trombotsitopenicheskoy purpury) u vzroslykh. Gematologiya i transfuziologiya. - Hematology and transfusiology. 2015;60(1):44-56. (In Russ.)]. 2. Ilnicki D., Wyderka R., Nowicki P., Sottowska A., Adamo-wicz J. [et al.]. A 64-year-old man suffering from ST-ele-vation myocardial infarction and severe thrombocytopenia: Procedures in the case of a patient not fitting the guidelines. SAGE Open Med. Case Rep. 2019;7:2050313X19840520. https://doi.org/10.1177/2050313X19840520 3. Rodeghiero F. Is ITP a thrombophilic disorder? Am. J. He-matol. 2016;91(1):39-45. https://doi.org/10.1002/ajh.24234 4. Doobaree I. U., Nandigam R., Bennett D., Newland A., 15. Provan D. Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis. Eur. J. Haematol. 2016;97(4):321-330. https://doi.org/10.1111/ejh.12777 5. Takagi S., Suzuki I., Watanabe S. Risk of Thromboembo- 16. lism in Patients with Immune Thrombocytopenia J. Hematol. Thromb. Dis. 2015;3:1. https://doi.org/10.4172/2329-8790.10001856. Ekstrand C., Linder M., Baricault B., Lafaurie M., Sailler L. [et al.]. Impact of risk factors on the occurrence of 17. arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - Results from two nationwide cohorts.Thromb.Res.2019;178:124- 131. 7. Langeberg W., Schoonen W., Eisen M., Gamelin L., 18. Stryker S. Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies. Int. J. Hematol. 2016;103:655-664. https://doi.org/10.1007/s12185-016-1974-6 8. Rodeghiero F. ITP and thrombosis: an intriguing associa- 19. tion. Blood Adv. 2017;1(24):2280. https://doi.org/10.1182/bloodadvances.2017007989 9. Norgaard M., Cetin K., Maegbaek M. L., Kristensen N., Ghanima W. [et al.]. Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: A Scandinavian popula tion-based cohort study. Br. J. Haematol. 2015;174(4):493 10. Maxmonov L.S., Mamatqulova F.X., Holiqulov B.Y. Gemorragik diatezlar bilan kasallangan ayollarda tuxumdon apopleksiyasi asoratini davolash tamoyillari //Science and Education. – 2022. – Т. 3. – №. 12. – С. 237-244. 11. Mamatkulova Feruza Khaydarovna, Akhmedov Husan Isrofilovich, Abdiev Kattabek Makhmatovich. Essential Thrombocythemia - Principal Analysis in Children and Adolescents. JOURNAL OF INTELLECTUAL PROPERTY AND HUMAN RIGHTS Volume: 2 Issue: 10 | Oct – 2023 ISSN: 2720-6882. 23-29. 12. FX Mamatkulova, SF Ziyodinov, DX Suyundiqov. Yurak-qon tomir kasalliklari bo ‘lgan bemorlarda qonining elektrokinetik va klinik- laborator ko ‘rsatmalari. Science and Education 5 (2), 154-160 13. F.X.Mamatkulova., X.I.Axmedov. Temir tanqisligi kamqonligining kelib chiqish sabablari va davolashga zamonaviy yondoshuv. “SCIENCE AND EDUCATION” VOLUME 4,ISSUE1.2023/195-203 14. Dadajonov, U., Abdiyev, K., Mamatkulova, F., & Dadajonov, U. (2021). Innovatsionniye metodi lecheniya immunnoy trombotsitopenicheskoy purpuri u lits molodogo vozrasta. Obshestvo i innovatsii, 2(4/S), 52-56. 15.KM Abdiev, AG Madasheva, FK Mamatkulova Мodern methods of treatment of hemorrhagic syndrome at an early stage in patients with idiopathic thrombocytopenic purpura. ученый xxi века, 41-44 16. MF Khaydarovna, AH Isrofilovich, AK Makhmatovich Essential Thrombocythemia-Principal Analysis in Children and Adolescents. Journal of Intellectual Property and Human Rights 2 (10), 23-29